JPRN-jRCT2031210470进行中（未招募）2 期
A Phase 2/3, Randomized, Observer-Blind, Active-Controlled Study to Evaluate the Immunogenicity of a Booster Dose of S-268019 or COMIRNATY (COVID-19)
agata Tsutae0 个研究点目标入组 204 人开始时间: 2021年12月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 204
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Participant must be >= 20 years of age inclusive, at the time of signing the informed consent.
- •Participant who have received 2 doses of COMIRNATY and at least 6 months post second dose.
排除标准
- •Positive SARS-CoV-2 antigen test result at Screening.
- •A known history of SARS-CoV-2 infection as determined by medical interview before study intervention.
- •Participant has a contraindication to IM injections or blood draws.
研究者
相似试验
进行中（未招募）
2 期
A Phase 2/3 Study of S-268019 in Adults over 60 years of ages(COVID-19)JPRN-jRCT2031220224agata Tsutae180
进行中（未招募）
2 期
A Phase 2/3 Study of S-268019 in Participants Aged 12 to 19 Years(COVID-19)JPRN-jRCT2031220063agata Tsutae350
进行中（未招募）
1 期
A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19SARS-CoV-2EUCTR2022-000063-51-Outside-EU/EEAModernaTX, Inc.
进行中（未招募）
3 期
A Phase 3 Study to Compare the Immunogenicity against COVID-19, of S-268019 to the ChAdOx1 nCoV-19 vaccine (COVID-19)JPRN-jRCT2051210151agata Tsutae1,000
进行中（未招募）
3 期
A Booster Study of S-268023 (COVID-19)Prevention of COVID-19JPRN-jRCT2031230503Gomez Juan Carlos600